Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P14784 (
IL-2 receptor
)
3,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study we investigated the serum levels of the soluble forms of CD4 (sCD4), CD8 (sCD8) and
IL-2 receptor
(sIL-2R) in 15 patients with acute cytomegalovirus
mononucleosis
utilizing three different enzyme immunosorbent assays. The control population consisted of 10 normal healthy blood donors of the same age group. Soluble CD8 and IL-2R concentration was significantly higher in the first group of patients than in blood donors while there were no significant differences of sCD4 levels between the two groups. We studied the kinetic of release of sCD8 and sIL-2R during the convalescent phase in 8 patients and the data we have obtained suggest that sCD8 and sIL-2R may be of value in monitoring T cells activation during CMV
mononucleosis
.
...
PMID:Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome. 166 53
The lymphocytosis manifested in
infectious mononucleosis
(IM) during acute phase is ascribed to a reactive expansion of CD8+ T lymphocytes caused by Epstein-Barr virus (EBV)-infected B lymphocytes. Expression of HLA-DR antigen on IM lymphocytes suggests that these T lymphocytes are somehow activated in vivo. In the present study, we analyzed the interleukin-2 (IL-2) receptor expression on lymphocytes from six patients with acute IM. Radiolabeled IL-2 binding assay revealed that IM lymphocytes from all patients examined had a considerable number of IL-2 binding sites with an intermediate affinity, although they did not express the
IL-2 receptor
recognized by anti-Tac antibody (p55). The number of binding sites (1,070 to 4,600 sites per cell) was larger than that of a normal, resting T lymphocyte-enriched population (650 sites per cell). Furthermore, IM lymphocytes showed marked proliferative responses to higher concentrations of IL-2, which were almost completely blocked by an anti-p70
IL-2 receptor
antibody, indicating that their
IL-2 receptor
is a functional receptor. The results of an affinity cross-linking study seem to indicate that the
IL-2 receptor
expressed on IM lymphocytes is p70, the second chain of the
IL-2 receptor
distinct from p55. Flow cytometric analysis following immunofluorescent staining with anti-p70
IL-2 receptor
antibody confirmed p70 expression on CD8+ HLA-DR+ lymphocytes. These data suggest that p70
IL-2 receptor
expression is involved in the immune response triggered by EBV infection.
...
PMID:Selective expression of the p70 subunit of the interleukin-2 receptor on lymphocytes from patients with infectious mononucleosis. 229
Epstein-Barr virus (EBV) has a marked tropism for cells of the immune system, and infection can result in profound immunomodulatory effects. In order to examine the role of cytokines during the acute phase of
infectious mononucleosis
, we studied the levels of different interleukins (ILs), interferons (IFNs), and the soluble
IL-2 receptor
(sIL-2R) in serum samples of 20 patients. We found elevated levels of IL-2, IL-6, sIL-2R, and IFN-gamma. Whereas the peak of IL-2 and IL-6 concentration occurred during the first week (P < 0.01), the largest amounts of sIL-2R were measured during the second week (P < 0.01). IFN-gamma levels were only enhanced during the first week. In addition, we investigated the ability to produce cytokines in response to mitogenic stimulation in a whole-blood assay of 11 patients compared with healthy blood donors. In the whole-blood assay of patients compared with controls after stimulation with lipopolysaccharide, we measured more than 10-fold elevated levels of tumor necrosis factor alpha (P < 0.01), 3-fold elevated levels of IL-1 beta (P < 0.01), and about 2-fold increased amounts of IL-6 (P < 0.01). A significant enhancement in sIL-2R and IFN-gamma concentration was found in the assay after stimulation with phytohemagglutinin after 24 h of incubation (P < 0.01). Collectively, our data seem to indicate that monocytes are strongly activated during
infectious mononucleosis
. Monocytes and monocyte-derived factors may play an important role in the pathogenesis of
infectious mononucleosis
and, together with T lymphocytes, may be partly responsible for clinical symptoms.
...
PMID:Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo. 769 31
The clinical picture of
infectious mononucleosis
and the consequences of EBV infection are due to immune response mechanisms. The level of soluble form of
IL-2 receptor
(sIL-2R) is thought to be a marker of T-cell activity, especially CD8+. Intercellular adhesion molecule (ICAM-1, CD 54) plays an important role in the process of antigen presentation. The aim of this study was to assess the serum concentration of sIL-2R, ICAM-1 and anti-VCA IgM in patients with
infectious mononucleosis
. The study group comprised 42 persons: 20 healthy subjects as a control group and 22 individuals with
infectious mononucleosis
. The highest anti-VCA IgM serum level in all patients was during the 1st day of hospitalization, and decreased in the 8th day of hospitalization. The lowest antibody concentration was observed when the symptoms and sings ceased. The level of sIL-2R was significantly increased and during farther hospitalization we observed lower, but still elevated concentrations. Our study has demonstrated statistically significant elevation of sICAM-1 level during the entire period of hospitalization. This data indicates the importance of antigen presentation process. Although the serum concentration of immune response mediators does not reflect their contents in organism, but is a useful method for in vivo examination.
...
PMID:[Levels of soluble intracellular adhesion molecules 1 (sICAM-1) , soluble receptors for interleukin 2 (sIL-2R) and anti-Epstein-Barr viral capsid antigen (anti-VCA IgM) in blood serum during the course of infectious mononucleosis]. 1143 83
Serum levels of interleukin-16 (IL-16) were measured to investigate its role in the pathophysiology of hemophagocytic lymphohistiocytosis (HLH). Serum IL-16 levels in patients with acute HLH were significantly higher than those in healthy controls and patients with
infectious mononucleosis
. They returned to normal levels in the convalescent phase of the disease. In contrast to serum interferon-gamma (IFN-gamma) levels, serum IL-16 levels showed a gradual decrease over the course of the disease. Serum IL-16 levels showed a significant positive correlation with serum levels of soluble
IL-2 receptor
, IFN-gamma, and interleukin-18, body temperature, and serum lactic dehydrogenase (LDH) levels. An increase in IL-16 mRNA expression was detected in the liver of an HLH patient. These results suggest that IL-16 plays an important role in the pathophysiology of HLH by TH1 cell recruitment and activation at organs with inflammation.
...
PMID:Increased IL-16 levels in hemophagocytic lymphohistiocytosis. 1534 83